Publications

Spatial clustering of drug-resistant tuberculosis in Hlabisa subdistrict, KwaZulu-Natal, 2011-2015.

Smith, CM; LESSELLS, R; GRANT, AD; Herbst, K; Tanser, F;

2017

The international journal of tuberculosis and lung disease, (2017).22 3 10.5588/ijtld.17.0457.

A strong TB programme embedded in a developing primary healthcare system is a lose-lose situation: insights from patient and community perspectives in Cambodia.

SUNDARAM, N; James, R; Sreynimol, U; Linda, P; Yoong, J; Saly, S; Koeut, P; Eang, MT; COKER, R; KHAN, MS;

2017

Health policy and planning, (2017).32 suppl_ 10.1093/heapol/czx079.

The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis.

DHEDA, K; Gumbo, T; Maartens, G; Dooley, KE; McNerney, R; Murray, M; Furin, J; Nardell, EA; London, L; Lessem, E; Theron, G; Van Helden, P; Niemann, S; Merker, M; Dowdy, D; Van Rie, A; Siu, GK H; Pasipanodya, JG; Rodrigues, C; CLARK, TG; Sirgel, FA; Esmail, A; Lin, H-H; Atre, SR; Schaaf, HS; ... Warren, RM.

2017

The lancet Respiratory medicine, (2017).5 4 10.1016/S2213-2600(17)30079-6.

Minimum inhibitory concentration distributions for first- and second-line antimicrobials against Mycobacterium tuberculosis.

BURKE, RM; Coronel, J; MOORE, D;

2017

Journal of medical microbiology, (2017).66 7 10.1099/jmm.0.000534.

The duration of protection of school-aged BCG vaccination in England: a population-based case-control study.

MANGTANI, P; NGUIPDOP-DJOMO, P; KEOGH, RH; Sterne, JA C; Abubakar, I; SMITH, PG; FINE, PE M; VYNNYCKY, E; Watson, JM; Elliman, D; Lipman, M; RODRIGUES, LC;

2017

International journal of epidemiology, (2017).47 1 10.1093/ije/dyx141.

Development of a non-human primate BCG infection model for the evaluation of candidate tuberculosis vaccines.

Harris, SA; White, A; STOCKDALE, L; Tanner, R; Sibley, L; Sarfas, C; Meyer, J; Peter, J; O'Shea, MK; Manjaly Thomas, Z-R; Hamidi, A; Satti, I; Dennis, MJ; McShane, H; Sharpe, S;

2017

Tuberculosis (Edinburgh, Scotland), (2017).108, 10.1016/j.tube.2017.11.006.

Symptom screening rules to identify active pulmonary tuberculosis: Findings from the Zambian South African Tuberculosis and HIV/AIDS Reduction (ZAMSTAR) trial prevalence surveys.

Claassens, MM; Van Schalkwyk, C; FLOYD, S; AYLES, H; Beyers, N;

2017

PloS one, (2017).12 3 10.1371/journal.pone.0172881.

The impact of pyrazinamide resistance on the treatment outcome of patients with multidrug-resistant tuberculosis in Karakalpakstan, Uzbekistan.

Kuhlin, J; SMITH, C; Khaemraev, A; Tigay, Z; Parpieva, N; Tillyashaykhov, M; Achar, J; Hajek, J; Greig, J; Du Cros, P; MOORE, D;

2017

(2017).

Modelling the social and structural determinants of tuberculosis: opportunities and challenges.

PEDRAZZOLI, D; BOCCIA, D; Dodd, PJ; Lönnroth, K; Dowdy, DW; Siroka, A; Kimerling, ME; WHITE, RG; HOUBEN, RM G J;

2017

The international journal of tuberculosis and lung disease, (2017).21 9 10.5588/ijtld.16.0906.

Comparison of two cash transfer strategies to prevent catastrophic costs for poor tuberculosis-affected households in low- and middle-income countries: An economic modelling study.

RUDGARD, WE; Evans, CA; SWEENEY, S; Wingfield, T; Lönnroth, K; Barreira, D; BOCCIA, D;

2017

PLoS medicine, (2017).14 11 10.1371/journal.pmed.1002418.